H-1B sponsorship profile: Sastra Cell Therapy. Across U.S. Department of Labor LCA disclosures, Sastra Cell Therapy filed 3 Labor Condition Applications covering 3 H-1B worker positions between fiscal year 2023 and fiscal year 2023. The employer’s DOL certification rate sits at 100% (3 certified of 3 filed), a useful proxy for how cleanly their prevailing-wage attestations pass the Labor Department’s preliminary review before USCIS adjudication.

Compensation spread. Offered wages on Sastra Cell Therapy’s H-1B petitions range from $140,000 at the low end to $170,000 at the high end, with a petition-weighted average of $150,000. That range reflects the mix of occupations the company sponsors, led by Scientist (2 petitions at $140,000 avg), followed by Principal Scientist. H-1B salaries reported on LCAs must meet or exceed the DOL prevailing wage for the role and worksite, so the spread also tracks wage-level geography and seniority.

Geographic footprint. Sastra Cell Therapy is headquartered in Palo Alto, CA under NAICS code 541714, and places H-1B workers across 1 state, most heavily in CA. Combined, these signals give a granular view of how one employer uses the H-1B program, volume, approval cleanliness, wage posture, and where the jobs actually sit on the map.

Where Sastra Cell Therapy ranks. By H-1B petition volume, Sastra Cell Therapy is #37,433 of 119,880 employers nationally and #6,671 of 22,893 employers headquartered in CA. Both ranks are computed live from the same underlying petition counts, not a separate estimate.